Clinical significance of CD151 gene expression in non-small cell lung cancer

Clinical Cancer Research

Volumn 7, Issue 12, 2001, Pages 4109-4114

  Tokuhara, Takahiro ^a,c   Hattori, Noboru ^a   Ishida, Hisao ^a   Taki, Toshihiko ^a   Miyake, Masayuki ^a   Hasegawa, Hitoshi ^b   Tachibana, Shuuichi ^c   Sasaki, Sinjiroh ^c  

^a Kitano Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; CD82 ANTIGEN; CD9 ANTIGEN; GENE PRODUCT; PROTEIN PETA3; PROTEIN TM4SF; UNCLASSIFIED DRUG;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER STAGING; CD151 GENE; CELL ACTIVATION; CELL MOTILITY; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENE ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIGENE FAMILY; ONCOGENE; PETA3 GENE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035678765     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. The ins and outs of the transmembrane 4 superfamily
2. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA
3. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
4. CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma
5. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer
6. Correlation of motility related protein-1 (MRP-1/CD9) gene expression with poor prognosis of patients with non-small cell lung cancer
7. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer
8. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
9. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
10. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients
11. Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3
12. SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily
13. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis
14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
15. Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns
16. Rare spontaneously transformed human endothelial cell line provides useful research tool
17. Nonparametric estimation from incomplete observations
18. Evaluation of survival data and two new rank order statistics arising in its consideration
19. Regression models and life-tables
20. Cathepsin D and prognosis in breast cancer
21. Assignment of SFA-1 (PETA-3), a member of the transmembrane 4 superfamily, to human chromosome 11p15.5 by fluorescence in situ hybridization
22. The monoclonal antibody, 14A2.H1, identifies a novel platelet surface antigen
23. Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen
24. Location of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: Comparison with CD9, CD63, and a5b1 integrin
25. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with α3 β1 integrin location at endothelial lateral junctions
26. SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with α5β1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin
27. Selective tetraspan-integrin complexes (CD81/α4β1, CD151/α3β1, CD151/α6β1) under conditions disrupting tetraspan interaction
28. PETA-3/CD151, a member of the transmembrane 4 superfamily, is localized to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function
29. Surgical treatment of lung cancer
30. First Euro-American forum on lung cancer treatment
31. Revisions in the international system for staging lung cancer
32. Survival after resection of stage II non-small cell lung cancer
33. Novel staging protocol for non-small cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression
34. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin
35. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases
36. A novel molecular staging protocol for non-small cell lung cancer